Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170378 · ClinicalTrials.gov registry record · Phase 4
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
A Phase 4 study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00170378 is a Phase 4 study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 300 participants.
The verdict
NCT00170378, a Phase 4 study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.
Interventions
- DRUG Enoxaparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2002-12 |
| Est. Completion | 2005-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00170378
The ClinicalTrials.gov registry entry for NCT00170378 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enoxaparin is the first listed.
NCT00170378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00170378 about?
NCT00170378 is a clinical study titled "The Use of Low Molecular Weight Heparin in Traumatic Brain Injury". To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.
What is the current status of trial NCT00170378?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2002-12. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00170378?
The interventions under investigation include: Enoxaparin (DRUG).
Who is sponsoring clinical trial NCT00170378?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.